Blue Bird School Bus Foundation Donates $60,000 to Eleven Leading Community Groups in its Home State MACON, Ga.–(BUSINESS WIRE)–The Blue Bird School Bus Foundation, charitable arm of iconic school bus manufacturer Blue Bird Corporation (Nasdaq: BLBD), continues to invest in the education, health, and safety of children in its home state of Georgia. The Foundation … [Read more…]
BOSTON–(BUSINESS WIRE)–Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chair & Chief Executive Officer is scheduled to present at Jefferies Global Healthcare Conference on Tuesday, November 18, 2025, in London. About Novanta Novanta is a leading global supplier of core technology … [Read more…]
NEWARK, Calif.–(BUSINESS WIRE)–#AchillesRepair—Aztron Medtech, a privately held orthopedic device company, today announced that its flagship product, the TendMIN™ Minimally Invasive Achilles Repair System, is now listed on the Federal Supply Schedule (FSS), the Defense Logistics Agency’s Electronic Catalog (ECAT) and the GSA Advantage platform through its partnership with Lovell Government Services (LGS), a Service-Disabled Veteran-Owned … [Read more…]
Green certification is the top tier of the globally recognized My Green Lab program for laboratory sustainability excellence RANCHO CORDOVA, Calif.–(BUSINESS WIRE)–SK pharmteco, a global contract development and manufacturing organization (CDMO), today announced a significant milestone in its commitment to environmental sustainability by earning four My Green Lab certifications, including two at the program’s highest … [Read more…]
Milestone expands India’s role in global biologics manufacturing; collaboration with Cipla underscores commitment to quality and reliability BENGALURU, India–(BUSINESS WIRE)–Kemwell Biopharma Pvt Ltd (“Kemwell”), a leading global biologics Contract Development and Manufacturing Organization (CDMO), announced today that its drug-product manufacturing facility in Bengaluru has successfully completed a U.S. Food and Drug Administration (FDA) pre-approval inspection … [Read more…]
CHICAGO–(BUSINESS WIRE)–Investigators from Hospital for Special Surgery (HSS) presented provocative evidence showing how social determinants of health (SDOH) and perceived discrimination influence the care and outcomes of people with rheumatologic diseases, such as lupus, and demonstrated how healthcare providers can screen for SDOH during patient encounters. They made these presentations at ACR Convergence 2025, the … [Read more…]
Third quarter TRCV* increased 8% year-over-year to $141.7 million Cash flow from operations increased 46% year-over-year to $13.8 million LINCOLN, Neb.–(BUSINESS WIRE)–National Research Corporation, dba NRC Health, (NASDAQ: NRC), a leader in healthcare experience improvement solutions, today announced results for the third quarter 2025. “We delivered our fourth consecutive quarter of recurring contract value growth, … [Read more…]
Analyses from the two Phase 3 RITA trials evaluate both the suitability of age-based dosing as well as the tolerability of treatment with follitropin delta in women undergoing controlled ovarian stimulation. Ferring’s long-standing commitment to helping people build families is illustrated through the company’s investment in developing innovative potential treatment options that advance the science … [Read more…]
RestorixHealth adds top-tier hospitals, academic medical centers and hospital systems, expanding to nearly 300 partners across 41 states Combined expertise offers more comprehensive management solutions for partners and supports further growth opportunities METAIRIE, La.–(BUSINESS WIRE)–#WhereHealingHappens–RestorixHealth, the nation’s leading wound care solutions company, today announced it has successfully completed a transaction to acquire CūtisCare, a leader … [Read more…]
Advancing a once-annual preventive RNAi medicine designed to reduce the two key drivers of cardiovascular disease: LDL-C and blood pressure Filed application for COR-1004, a novel siRNA targeting PCSK9 to reduce LDL-C BOSTON–(BUSINESS WIRE)–Corsera Health, Inc., leading the future of cardiovascular health through prediction and prevention, today announced the filing of a clinical trial notification … [Read more…]
